NASDAQ: ALCYAlchemy Investments Acquisition Corp 1 Stock
$11.72+0.00 (+0%)
Updated Jun 13, 2025
ALCY Price
$11.72
Fair Value Price
N/A
Market Cap
$53.12M
52 Week Low
$10.68
52 Week High
$13.14
P/E
73.25x
P/B
-7.44x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.53M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.08
Operating Cash Flow
-$907k
Beta
-0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ALCY Overview
Alchemy Investments Acquisition Corp 1, a special purpose acquisition company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It plans to focus on companies acquiring, processing, analysing, and utilizing data acquired from various systems and sources. The company was incorporated in 2021 and is based in Newark, Delaware.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ALCY's potential to beat the market
- ALCY doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
ALCY
RankedUnranked of 40
RankedUnranked of 40
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.13 | C | |
| $10.60 | C | |
| $10.02 | C |
Be the first to know about important ALCY news, forecast changes, insider trades & much more!
ALCY News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALCY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALCY was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALCY is poor value based on its earnings relative to its share price (73.25x), compared to the US market average (31.36x)
P/E vs Market Valuation
ALCY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ALCY due diligence checks available for Premium users.
Valuation
ALCY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
73.25x
Industry
15.6x
Market
31.36x
ALCY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ALCY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
ALCY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.44x
Industry
-59.45x
ALCY's financial health
Profit margin
Revenue
$0.0
Net Income
-$301.5k
Profit Margin
0%
ALCY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$12.5M
Liabilities
$7.7M
Debt to equity
-1.08
ALCY's short-term liabilities ($2.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALCY's long-term liabilities ($5.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALCY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALCY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$429.2k
Investing
$0.0
Financing
-$114.1M
ALCY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ALCY vs Shell Company Stocks
Alchemy Investments Acquisition 1 Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.